PS
PFE icon

PayPay Securities’s Pfizer PFE Stock Holding History

PayPay Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14K Buy
255
+76
+42% +$1.99K 0.15% 98
2026
Q1 		$4.87K Buy
179
+43
+32% +$1.15K 0.17% 110
2025
Q4 		$3.39K Buy
136
+18
+15% +$454 0.1% 146
2025
Q3 		$3K Sell
118
-8
-6% -$197 0.11% 131
2025
Q2 		$3.05K Sell
126
-17
-12% -$396 0.15% 103
2025
Q1 		$3.65K Sell
143
-25
-15% -$654 0.21% 88
2024
Q4 		$4.46K Buy
168
+24
+17% +$651 0.19% 86
2024
Q3 		$4.17K Sell
144
-79
-35% -$2.31K 0.37% 61
2024
Q2 		$6.24K Sell
223
-13
-6% -$358 0.52% 37
2024
Q1 		$6.55K Sell
236
-8
-3% -$222 0.33% 59
2023
Q4 		$7.04K Sell
244
-26
-10% -$786 0.35% 58
2023
Q3 		$8.96K Buy
270
+142
+111% +$5.02K 0.41% 68
2023
Q2 		$4.7K Hold
128
– – 0.29% 47
2023
Q1 		$5.22K Sell
128
-96
-43% -$4.15K 0.35% 53
2022
Q4 		$11.5K Buy
+224
New +$10.7K 0.77% 28

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PayPay Securities's PFE Position: Q2 2026 in Review

PayPay Securities increased its Pfizer (PFE) stake by 42% in Q2 2026, buying an estimated $1.99K and bringing the position to 255 shares worth $6.14K. The position accounts for 0.15% of the portfolio, ranked #98.

PayPay Securities first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.5K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PayPay Securities held 255 shares of Pfizer worth $6.14K as of Q2 2026.
  • PayPay Securities bought 76 Pfizer shares in Q2 2026, an estimated $1.99K.
  • Pfizer made up 0.15% of PayPay Securities's portfolio in Q2 2026, its #98 holding.
  • PayPay Securities first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Pfizer position peaked at $11.5K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.